Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04710719 · ClinicalTrials.gov registry record · NA
Post-Surgical Injection With Triamcinolone Versus Triamcinolone/Fluorouracil in Treatment of Keloids
A NA study, sponsored by Our Lady of the Lake Hospital.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT04710719 is a NA study that has completed, run by Our Lady of the Lake Hospital. The registered enrollment target is 7 participants.
The verdict
NCT04710719, a NA study, has completed, sponsored by Our Lady of the Lake Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
There have been many modalities utilized in the treatment of keloids of the head and neck, however none have been universally successful. The most widely utilized non-surgical intervention is primary intralesional injection with triamcinolone (TAC) which inhibits the proliferation of fibroblasts, inhibits collagen synthesis, and increases collagenase production, or fluorouracil (5-FU), a potent inhibitor of fibroblast proliferation. Despite the abundance of studies evaluating primary intralesional injection for keloids, there are limited studies available regarding the efficacy of primary surgical excision followed by adjuvant intralesional injection. The proposed study herein would serve to improve the level of evidence and to establish the safety and efficacy of combined intralesional TAC+5FU for keloids following surgical excision.
Interventions
- DRUG Triamcinolone Injection
- DRUG Triamcinolone Injection and 5-fluorouracil injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2022-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04710719
The ClinicalTrials.gov registry entry for NCT04710719 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Our Lady of the Lake Hospital, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Triamcinolone Injection is the first listed.
NCT04710719 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04710719 about?
NCT04710719 is a clinical study titled "Post-Surgical Injection With Triamcinolone Versus Triamcinolone/Fluorouracil in Treatment of Keloids". There have been many modalities utilized in the treatment of keloids of the head and neck, however none have been universally successful. The most widely utilized non-surgical intervention is primary intralesional injection with triamcinolone (TAC) which inhibits the proliferation of fibroblasts, in...
What is the current status of trial NCT04710719?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2021-02-01. Estimated completion is 2022-07-01.
What interventions are being tested in trial NCT04710719?
The interventions under investigation include: Triamcinolone Injection (DRUG), Triamcinolone Injection and 5-fluorouracil injection (DRUG).
Who is sponsoring clinical trial NCT04710719?
This trial is sponsored by Our Lady of the Lake Hospital, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.